Hantz Financial Services, Inc. Charles River Laboratories International, Inc. Transaction History

Hantz Financial Services, Inc.

$5.74 Billion
Q4 2024

A detailed history of Hantz Financial Services, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 823 shares of CRL stock, worth $135,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

823

Previous 36,657 97.75%

Holding current value

$135,770

Previous $7.22 Million 97.89%

% of portfolio

0.0%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$178.58 - $220.69 $6.4 Million - $7.91 Million	-35,834 Reduced 97.75%	823 $152,000
Q3 2024 Nov 13, 2024	SELL	$187.96 - $245.29 $270,662 - $353,217	-1,440 Reduced 3.78%	36,657 $7.22 Million
Q2 2024 Jul 30, 2024	BUY	$206.39 - $268.73 $7.86 Million - $10.2 Million	38,097 New	38,097 $7.87 Million
Q1 2024 Aug 06, 2024	SELL	$203.52 - $273.43 $445,098 - $597,991	-2,187 Reduced 5.22%	39,737 $10.8 Million
Q4 2023 Aug 06, 2024	SELL	$164.52 - $238.84 $527,780 - $766,198	-3,208 Reduced 7.11%	41,924 $9.91 Million
Q3 2023 Aug 06, 2024	BUY	$194.44 - $217.61 $6,805 - $7,616	35 Added 0.08%	45,132 $8.85 Million
Q2 2023 Aug 06, 2024	BUY	$183.71 - $210.25 $85,057 - $97,345	463 Added 1.04%	45,097 $9.48 Million
Q1 2023 Aug 06, 2024	BUY	$191.89 - $259.92 $256,173 - $346,993	1,335 Added 3.08%	44,634 $9.01 Million
Q4 2022 Aug 06, 2024	BUY	$197.11 - $250.07 $268,266 - $340,345	1,361 Added 3.25%	43,299 $9.44 Million
Q3 2022 Aug 06, 2024	SELL	$182.44 - $250.54 $584,172 - $802,229	-3,202 Reduced 7.09%	41,938 $8.25 Million
Q2 2022 Aug 06, 2024	BUY	$204.13 - $302.4 $243,527 - $360,763	1,193 Added 2.71%	45,140 $9.66 Million
Q1 2022 Aug 06, 2024	SELL	$255.51 - $362.11 $2.38 Million - $3.38 Million	-9,333 Reduced 17.52%	43,947 $12.5 Million
Q4 2021 Aug 06, 2024	BUY	$351.38 - $448.68 $1.16 Million - $1.49 Million	3,312 Added 6.63%	53,280 $20.1 Million
Q3 2021 Aug 06, 2024	BUY	$372.64 - $458.3 $2.61 Million - $3.21 Million	7,009 Added 16.32%	49,968 $20.6 Million
Q2 2021 Aug 06, 2024	BUY	$294.17 - $371.65 $780,727 - $986,359	2,654 Added 6.58%	42,959 $15.9 Million
Q1 2021 Aug 06, 2024	BUY	$249.67 - $299.48 $551,271 - $661,251	2,208 Added 5.8%	40,305 $11.7 Million
Q4 2020 Aug 06, 2024	BUY	$222.0 - $252.62 $30,414 - $34,608	137 Added 0.35%	38,890 $9.72 Million
Q3 2020 Aug 06, 2024	BUY	$175.56 - $226.45 $7,022 - $9,058	40 Added 0.1%	38,753 $8.78 Million
Q2 2020 Aug 06, 2024	BUY	$118.84 - $189.72 $106,480 - $169,989	896 Added 2.37%	38,713 $6.75 Million
Q1 2020 Aug 06, 2024	SELL	$98.9 - $178.34 $27,692 - $49,935	-280 Reduced 0.73%	37,817 $4.77 Million

Others Institutions Holding CRL

# of Institutions

691

Shares Held

52M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.39B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Charles River Laboratories International, Inc. Transaction History